Results 41 to 50 of about 30,804 (255)
ENHANCEMENT OF THE ANTIDIABETIC EFFECT OF GLICLAZIDE BY THE ANTIPEPTIC DRUG OMEPRAZOLE IN ALLOXAN-INDUCED DIABETIC RATS [PDF]
Introduction: Diabetes mellitus (DM) is a global emerging disease with progressive incidence worldwide. Diabetic patients have a higher incidence of peptic ulcer disease than the non-diabetic population.
MAHMOUD ABDELRAHIM +2 more
doaj +1 more source
Background. The interrelation between omeprazole use and the possibility of developing nosocomial pneumonia, acute kidney damage and Clostridium difficile-induced diarrhea in patients with sepsis requires further study. Material and methods.
Oliynyk, O. +2 more
core +1 more source
Study on the Preparation Technology of Omeprazole Vesicles [PDF]
Herein a study on the process of converting omeprazole into omeprazole vesicles by a film dispersion method is presented. Using encapsulation efficiency as an index, the formulation and technology of omeprazole vesicles are optimized by a single factor ...
Wang, Zhimei +5 more
core +1 more source
(a) The outstanding lubricative properties of natural articular cartilage arise from a composite coating composed of HA, lubricin, and phospholipids at its surface. Notably, lubricin facilitates the enrichment of synovial HA onto cartilage surfaces, and HA complexes with phospholipids, a key component to maintain extremely low friction under high ...
Yongan Lin +12 more
wiley +1 more source
Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population [PDF]
Background: In Iran, there is insufficient information on the efficacy of Helicobacter pylori eradication regimens shorter than 10 days. This study aims at assessing the efficacy of 4- and 7-day H. pylori eradication regimens in a high-incidence area of
میکاییلی, جواد +15 more
core +1 more source
Multi‐Targeting Carnosic Acid Kills Drug‐Resistant Helicobacter pylori With Narrow‐Spectrum Activity
Carnosic acid selectively eradicates drug‐resistant Helicobacter pylori through a multi‐targeted mechanism involving urease inhibition, membrane disruption, and biofilm eradication. It exhibits no detectable resistance, potent in vivo efficacy, and minimal impact on gut microbiota, positioning it as a promising narrow‐spectrum lead compound against ...
Yuefan Bai +7 more
wiley +1 more source
Introduction The association between omeprazole and hypertension is poorly documented. The summary of product characteristics of omeprazole approved by major regulators did not mention hypertension as an adverse drug event.
Merhawi Bahta +4 more
doaj +1 more source
CSF omeprazole concentration and albumin quotient following high dose intravenous omeprazole in dogs. [PDF]
peer reviewedClinical signs of syringomyelia and hydrocephalus occur secondary to cerebrospinal fluid (CSF) accumulation within the central nervous system.
Girod, M +10 more
core +1 more source
Melatonin Levels in 89 Individuals With Smith Magenis Syndrome
ABSTRACT In patients with Smith–Magenis syndrome (SMS), an inverted circadian rhythm of melatonin (MT) contributes to the sleep disturbance. Standard treatment of sleep disturbance with MT often leads to extremely high daytime MT levels, resulting in even more sleep disorders. We therefore retrospectively evaluated the MT data of 89 SMS patients.
Wiebe Braam, Ann C. M. Smith
wiley +1 more source
Binding of omeprazole to protein targets identified by monoclonal antibodies.
Omeprazole is the most commonly used proton pump inhibitor (PPI), a class of medications whose therapeutic mechanism of action involves formation of a disulfide linkage to cysteine residues in the H+/K+ ATPase pump on gastric secretory cells.
Naw May Pearl Cartee, Michael M Wang
doaj +2 more sources

